Clascoterone and Finasteride Interaction
Clascoterone and Finasteride have a synergistic interaction with 95% confidence. Clascoterone and finasteride address androgen-driven hair loss through complementary mechanisms. Finasteride inhibits 5-alpha reductase to reduce systemic DHT production, while clascoterone blocks remaining androgens from activating the receptor at the follicle. This dual approach targets both the ligand supply and the receptor activation, potentially providing greater efficacy than either agent alone. Both compounds affect the skin, so monitoring these systems is recommended.
Compound Profiles
Clascoterone
Topical Androgen Receptor Inhibitor | Acne & Hair Loss
Clascoterone acts as a competitive antagonist of the androgen receptor (AR). When applied topically, it penetrates the skin and binds directly to androgen receptors in target tissues -- sebaceous glands (for acne) and dermal papilla cells of hair follicles (for alopecia).
View full profileFinasteride
5-Alpha Reductase Inhibitor | DHT Blocker for Hair Loss & BPH
Finasteride competitively and selectively inhibits the Type II isoform of the enzyme 5-alpha reductase, which is predominantly found in hair follicles, the prostate, and the liver. This enzyme converts testosterone into dihydrotestosterone (DHT).
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Clascoterone with Finasteride?
Yes, Clascoterone and Finasteride can generally be taken together. Clascoterone and finasteride address androgen-driven hair loss through complementary mechanisms. Finasteride inhibits 5-alpha reductase to reduce systemic DHT production, while clascoterone blocks remaining androgens from activating the receptor at the follicle. This dual approach targets both the ligand supply and the receptor activation, potentially providing greater efficacy than either agent alone.
Is Clascoterone and Finasteride safe together?
Based on documented research, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.
What are the interactions between Clascoterone and Finasteride?
Clascoterone and finasteride address androgen-driven hair loss through complementary mechanisms. Finasteride inhibits 5-alpha reductase to reduce systemic DHT production, while clascoterone blocks remaining androgens from activating the receptor at the follicle. This dual approach targets both the ligand supply and the receptor activation, potentially providing greater efficacy than either agent alone. This assessment has 95% confidence and is based on documented research data.
How should I time Clascoterone and Finasteride?
Clascoterone has a half-life of Short topical (local action; rapidly metabolized to cortexolone) and Finasteride has a half-life of 6-8 hours (DHT suppression persists ~24 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.